Pliant Therapeutics Inc (NASDAQ: PLRX) is -40.03% lower on its value in year-to-date trading and has touched a low of $10.29 and a high of $20.23 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PLRX stock was last observed hovering at around $10.52 in the last trading session, with the day’s gains setting it 0.34%.
Currently trading at $10.86, the stock is -1.94% and -12.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing 3.23% at the moment leaves the stock -26.73% off its SMA200. PLRX registered -40.85% loss for a year compared to 6-month loss of -41.86%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.25% gain in the last 1 month and extending the period to 3 months gives it a -25.87%, and is 1.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.10% over the week and 5.00% over the month.
Pliant Therapeutics Inc (PLRX) has around 158 employees, a market worth around $655.18M and $0.25M in sales. Profit margin for the company is -68847.98%. Distance from 52-week low is 5.54% and -46.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.76%).
with sales reaching $490k over the same period.The EPS is expected to shrink by -23.35% this year, but quarterly earnings will post -64.60% year-over-year. Quarterly sales are estimated to shrink -44.30% in year-over-year returns.
Pliant Therapeutics Inc (PLRX) Top Institutional Holders
The shares outstanding are 59.92M, and float is at 53.41M with Short Float at 12.37%.
Pliant Therapeutics Inc (PLRX) Insider Activity
The most recent transaction is an insider sale by Coulie Bernard,the company’sPresident and CEO. SEC filings show that Coulie Bernard sold 25,721 shares of the company’s common stock on Jan 17 ’24 at a price of $17.23 per share for a total of $0.44 million. Following the sale, the insider now owns 0.32 million shares.
Pliant Therapeutics Inc disclosed in a document filed with the SEC on Jan 17 ’24 that Lefebvre Eric (Chief Medical Officer) sold a total of 10,295 shares of the company’s common stock. The trade occurred on Jan 17 ’24 and was made at $17.23 per share for $0.18 million. Following the transaction, the insider now directly holds 0.16 million shares of the PLRX stock.
Still, SEC filings show that on Jan 17 ’24, Hull Hans (Chief Business Officer) disposed off 9,786 shares at an average price of $17.23 for $0.17 million. The insider now directly holds 185,069 shares of Pliant Therapeutics Inc (PLRX).
